- Home
- IBRX vs SFM Comparison
IBRX vs SFM Comparison
Compare IBRX & SFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBRX | SFM |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.9B |
| IPO Year | 2015 | 2013 |
Fundamental Metrics
Financial Performance| Metric | IBRX | SFM |
|---|---|---|
| Price | $7.94 | $78.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 11 |
| Target Price | $12.57 | ★ $110.55 |
| AVG Volume (30 Days) | ★ 31.4M | 2.8M |
| Earning Date | 05-18-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.71 | ★ 41.60 |
| EPS | N/A | ★ 5.31 |
| Revenue | $113,288,000.00 | ★ $8,806,159,000.00 |
| Revenue This Year | $88.57 | $9.03 |
| Revenue Next Year | $146.98 | $7.40 |
| P/E Ratio | ★ N/A | $14.83 |
| Revenue Growth | ★ 668.31 | 14.08 |
| 52 Week Low | $1.83 | $64.75 |
| 52 Week High | $12.43 | $182.00 |
Technical Indicators
Market Signals| Indicator | IBRX | SFM |
|---|---|---|
| Relative Strength Index (RSI) | 49.64 | 59.75 |
| Support Level | $2.27 | $76.76 |
| Resistance Level | $8.28 | $82.28 |
| Average True Range (ATR) | 1.03 | 3.39 |
| MACD | -0.33 | 0.60 |
| Stochastic Oscillator | 3.33 | 88.64 |
Price Performance
Historical ComparisonAbout IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.
About SFM Sprouts Farmers Market Inc.
Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.